Recommendations for the Deprescribing of Psychotropic Medications: A Consensus Statement From the American Society of Clinical Psychopharmacology Task Force - PubMed
4 hours ago
- #consensus
- #psychopharmacology
- #deprescribing
- The American Society of Clinical Psychopharmacology convened a panel of 45 international experts to develop consensus on psychotropic medication deprescribing.
- A Delphi survey and literature review identified key aspects of deprescribing, including risk-benefit assessments, pharmacokinetics, pharmacodynamics, and patient involvement.
- Consensus was achieved on 88% of statements, emphasizing the need for periodic review of pharmacotherapy regimens.
- Key recommendations include assessing medication adherence before deprescribing and considering deprescribing if treatment goals are met or response is inadequate.
- Deprescribing should involve patient participation, address psychological ramifications, and include close clinical monitoring post-deprescribing.
- The statement highlights the need for empirical trials to evaluate the safety and effectiveness of deprescribing protocols.